India News | Press Trust of India | Monday November 27, 2023
A higher dose of the COVID-19 drug, dexamethasone, may have less beneficial effects for patients in India as compared with those in Europe, according to a study published in The Lancet Regional Health - Southeast Asia journal.
www.ndtv.com